CAS RN: 1695533-44-8
4(3H)-Quinazolinone, 2-[[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]methyl]-3-[4-(1-methylethoxy)[1,1′-biphenyl]-3-yl]-
Product Availability
Choose a grade to view its available package options.
8 package records7 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260411 |
100mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20251229 |
10mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20260213 |
1mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20251206 |
250mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20251021 |
25mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20260214 |
50mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20260311 |
5mg |
In stock |
Shanghai | | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250715 |
5mg / 25mg / 100mg / 500mg |
Out of stock |
| 15 business days | Inquiry |
-
Product code:
starshine_CAS1695533-44-8
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
1695533-44-8 / 2-[[4-[2-(4-chlorophenoxy)acetyl]piperazin-1-yl]methyl]-3-(5-phenyl-2-propan-2-yloxyphenyl)quinazolin-4-one
Standard CAS: 1695533-44-8
Multi CAS: No
Basic Information
CAS
1695533-44-8
Multi CAS
No
Molecular Formula
C36H35ClN4O4
Molecular Weight
623.100000
Exact Mass
622.234683
SMILES
CC(C)OC1=C(C=C(C=C1)C2=CC=CC=C2)N3C(=NC4=CC=CC=C4C3=O)CN5CCN(CC5)C(=O)COC6=CC=C(C=C6)Cl
InChI
InChI=1S/C36H35ClN4O4/c1-25(2)45-33-17-12-27(26-8-4-3-5-9-26)22-32(33)41-34(38-31-11-7-6-10-30(31)36(41)43)23-39-18-20-40(21-19-39)35(42)24-44-29-15-13-28(37)14-16-29/h3-17,22,25H,18-21,23-24H2,1-2H3
InChIKey
WLPHOTYCGOGILE-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
45
Aromatic heavy atom count
28
Fraction Csp3
0.25
Rotatable bonds
9
H-bond acceptors
7
Molar refractivity
177.34
TPSA
76.9
LogP / Solubility
WLOGP
6.22
MLOGP
5.52
XLogP3
6.5
Consensus LogP
6.08
Log S (ESOL)
-7.49
Class (ESOL)
Insoluble
Log S (Ali)
-9.16
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-9.95
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.11
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
5.5